UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 825

Sortiert nach

ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research

Annals of oncology, 2019-09, Vol.30 (9), p.1417-1427

2019

Volltextzugriff (PDF)

Real-world prevalence of programmed death ligand 1 expression in locally advanced or metastatic non–small-cell lung cancer: The global, multicenter EXPRESS study

Lung cancer (Amsterdam, Netherlands), 2019-08, Vol.134, p.174-179

2019

Volltextzugriff (PDF)

A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance

Cancer gene therapy, 2015-09, Vol.22 (9), p.417-430

2015

Volltextzugriff (PDF)

Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy

British journal of cancer, 2008-02, Vol.98 (3), p.604-610

2008

Volltextzugriff (PDF)

E11. Quality assurance and breast cancer pathology

European journal of cancer (1990), 2014-03, Vol.50, p.S22-S23

2014

Volltextzugriff (PDF)

Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites

Histopathology, 2000-05, Vol.36 (5), p.415-420

2000

Volltextzugriff (PDF)

Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B

Histopathology, 2000-01, Vol.36 (1), p.8-16

2000

Volltextzugriff (PDF)

Quality indicators in breast cancer care

European journal of cancer (1990), 2010-09, Vol.46 (13), p.2344-2356

2010

Volltextzugriff (PDF)

Tumor mutational burden (TMB) standardization initiative: Establishing a consistent methodology for TMB measurement in clinical samples

Annals of oncology, 2018-10, Vol.29, p.viii45-viii45

2018

Volltextzugriff (PDF)

SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study

Annals of oncology, 2014-05, Vol.25 (5), p.1025-1032

2014

Volltextzugriff (PDF)

GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics

British journal of cancer, 2008-09, Vol.99 (6), p.939-948

2008

Volltextzugriff (PDF)

Cancer beyond organ and tissue specificity: Next‐generation‐sequencing gene mutation data reveal complex genetic similarities across major cancers

International journal of cancer, 2014-11, Vol.135 (10), p.2362-2369

2014

Volltextzugriff (PDF)

Hormone replacement therapy: pathobiological aspects of hormone-sensitive cancers in women relevant to epidemiological studies on HRT: a mini-review

Human reproduction (Oxford), 2005-08, Vol.20 (8), p.2052-2060

2005

Volltextzugriff (PDF)

Frequency of therapy-relevant staging shifts in colorectal cancer through the introduction of pN1c in the 7th TNM edition

European journal of cancer (1990), 2014-11, Vol.50 (17), p.2958-2965

2014

Volltextzugriff (PDF)

Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnostics

Virchows Archiv : an international journal of pathology, 2018-04, Vol.472 (4), p.557-565

2018

Volltextzugriff (PDF)

Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing

British journal of cancer, 2014-07, Vol.111 (2), p.413-420

2014

Volltextzugriff (PDF)

ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival

Journal of clinical pathology, 2004-11, Vol.57 (11), p.1160-1164

2004

Volltextzugriff (PDF)

ALK-Testing in non-small cell lung cancer (NSCLC): Immunohistochemistry (IHC) and/or fluorescence in-situ Hybridisation (FISH)?: Statement of the Germany Society for Pathology (DGP) and the Working Group Thoracic Oncology (AIO) of the German Cancer Society e.V. (Stellungnahme der Deutschen Gesellschaft für Pathologie und der AG Thorakale Onkologie der Arbeitsgemeinschaft Onkologie/Deutsche Krebsgesellschaft e.V.)

Lung cancer (Amsterdam, Netherlands), 2017-01, Vol.103, p.1-5

2017

Volltextzugriff (PDF)

The PI3K inhibitor LY294002 blocks drug export from resistant colon carcinoma cells overexpressing MRP1

Oncogene, 2006-03, Vol.25 (12), p.1743-1752

2006

Volltextzugriff (PDF)

Prognostic impact of neuroendocrine differentiation in high-grade serous ovarian carcinoma

Virchows Archiv : an international journal of pathology, 2015-03, Vol.466 (3), p.333-342

2015

Volltextzugriff (PDF)

High expression of RelA/p65 is associated with activation of nuclear factor-κB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis

British journal of cancer, 2007-08, Vol.97 (4), p.523-530

2007

Volltextzugriff (PDF)

Evaluation of Mucin-1 protein and mRNA expression as prognostic and predictive markers after neoadjuvant chemotherapy for breast cancer

Annals of oncology, 2013-09, Vol.24 (9), p.2316-2324

2013

Volltextzugriff (PDF)

RNA-based analysis of anaplastic lymphoma kinase (ALK) fusions in non-small cell lung cancer (NSCLC) cases showing immunohistochemistry/fluorescence in-situ hybridisation (IHC/FISH) discordance

Annals of oncology, 2018-10, Vol.29, p.viii656-viii656

2018

Volltextzugriff (PDF)

Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas

American journal of clinical pathology, 2001-12, Vol.116 (6), p.823-830

2001

Volltextzugriff (PDF)

Aktuelle Aspekte zur Tumorigenese und Ätiologie

Der Onkologe, 2014-07, Vol.20 (7), p.642-649

2014

Volltextzugriff (PDF)

1 – 25 von 825

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(628)
Mit Volltextzugriff
(712)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(675)
Deutsch
(151)
Japanisch
(85)
Russisch
(6)
Tschechisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research

Real-world prevalence of programmed death ligand 1 expression in locally advanced or metastatic non–small-cell lung cancer: The global, multicenter EXPRESS study

A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance

Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy

E11. Quality assurance and breast cancer pathology

Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites

Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B

Quality indicators in breast cancer care

Tumor mutational burden (TMB) standardization initiative: Establishing a consistent methodology for TMB measurement in clinical samples

SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study

GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics

Cancer beyond organ and tissue specificity: Next‐generation‐sequencing gene mutation data reveal complex genetic similarities across major cancers

Hormone replacement therapy: pathobiological aspects of hormone-sensitive cancers in women relevant to epidemiological studies on HRT: a mini-review

Frequency of therapy-relevant staging shifts in colorectal cancer through the introduction of pN1c in the 7th TNM edition

Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnostics

Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing

ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival

The PI3K inhibitor LY294002 blocks drug export from resistant colon carcinoma cells overexpressing MRP1

Prognostic impact of neuroendocrine differentiation in high-grade serous ovarian carcinoma

High expression of RelA/p65 is associated with activation of nuclear factor-κB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis

Evaluation of Mucin-1 protein and mRNA expression as prognostic and predictive markers after neoadjuvant chemotherapy for breast cancer

RNA-based analysis of anaplastic lymphoma kinase (ALK) fusions in non-small cell lung cancer (NSCLC) cases showing immunohistochemistry/fluorescence in-situ hybridisation (IHC/FISH) discordance

Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas

Aktuelle Aspekte zur Tumorigenese und Ätiologie

Suchergebnisse filtern